Suppr超能文献

[正常玻璃体及增生性视网膜疾病中5种玻璃体蛋白质的定量测定]

[Quantitative determination of 5 vitreal proteins in the normal vitreous body and proliferative retinal diseases].

作者信息

Clausen R, Weller M, Hilgers R D, Heimann K, Wiedemann P

机构信息

Abteilung für Netzhaut- und Glaskörperchirurgie, Universitäts-Augenklinik, Köln.

出版信息

Fortschr Ophthalmol. 1990;87(3):283-6.

PMID:2376377
Abstract

While progress in vitreoretinal surgery has been very rapid in recent years, our understanding of the biochemistry of normal and pathological vitreous is still limited. Therefore, we developed non-competitive ELISA techniques for the quantification of five vitreal proteins which, together with vitreal collagen (300 mg/l), account for more than 70% of the total vitreal protein. Physiological levels of the individual proteins were determined as follows: albumin 293 +/- 18 mg/l, IgG 34 +/- 3 mg/l, transferrin 74 +/- 7 mg/l, alpha 1-antitrypsin 14 +/- 3 mg/l, alpha 1-acid glycoprotein 4 +/- 0.7 mg/l. Mean values for these proteins were also obtained in vitreous aspirates from patients with traumatic proliferative vitreoretinopathy (PVR) (n = 10), idiopathic PVR (n = 10) and proliferative diabetic retinopathy (PDR) (n = 15). Significant differences were found for total vitreal protein and alpha 1-antitrypsin between the control groups and the three vitreoretinal disorders, between the PDR and control group for transferrin, and between both types of PVR and controls for alpha 1-acid glycoprotein. Given the high plasma levels of the individual proteins quantified in this study and the uniform rise in total vitreal protein, a disturbancee of blood-retinal and blood-vitreal barriers seems to be an essential features of proliferative intraocular disorders. No disease-specific change in the protein pattern could be detected for the three disorders examined.

摘要

近年来,玻璃体视网膜手术进展迅速,但我们对正常及病理状态下玻璃体生物化学的了解仍很有限。因此,我们开发了非竞争性酶联免疫吸附测定(ELISA)技术来定量检测五种玻璃体蛋白,这些蛋白与玻璃体胶原蛋白(300毫克/升)一起,占玻璃体总蛋白的70%以上。各蛋白的生理水平测定如下:白蛋白293±18毫克/升,免疫球蛋白G(IgG)34±3毫克/升,转铁蛋白74±7毫克/升,α1-抗胰蛋白酶14±3毫克/升,α1-酸性糖蛋白4±0.7毫克/升。我们还从患有外伤性增殖性玻璃体视网膜病变(PVR)(n = 10)、特发性PVR(n = 10)和增殖性糖尿病视网膜病变(PDR)(n = 15)的患者玻璃体抽吸物中获得了这些蛋白的平均值。在对照组与三种玻璃体视网膜疾病之间,PDR与对照组之间的转铁蛋白,以及两种类型的PVR与对照组之间的α1-酸性糖蛋白,在玻璃体总蛋白和α1-抗胰蛋白酶方面发现了显著差异。鉴于本研究中定量检测的各蛋白血浆水平较高以及玻璃体总蛋白的一致升高,血视网膜屏障和血玻璃体屏障的破坏似乎是增殖性眼内疾病的一个基本特征。在所检查的三种疾病中未检测到蛋白模式的疾病特异性变化。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验